ArticlePharmaceuticals (Basel, Switzerland)2024

The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.

Apostolis Papaefthymiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.